GH Research PLC GHRS
19.10 USD +0.61 (+3.30%)
At closeNov 13, 2026, 4:36 PM EST
18.73 -0.37 -1.94%
After hours · Nov 13, 4:36 PM ET
18.00 Day range 19.79
12.48 52-week range 30.64
- YTD
- +50.39%
- 1 year
- +39.21%
News
benzinga.com GH Research Q3 EPS $(0.18) Beats $(0.32) Estimate GH Research (NASDAQ:GHRS) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.32) by 43.75 percent. This is a 21.74 percent increase over losses of $(0.23)…
globenewswire.com GH Research Reports Third Quarter 2026 Financial Results and Provides Business Update Novel GH001 Aerosol Delivery System (ADS) device: final results of the GH001-HV-106 trial support going from 3 → 1 doses per treatment visit TRD pivotal program — positive initial feedback from FDA,…
globenewswire.com GH Research Announces Appointment of Vanina Popova, MD, as Chief Development Officer DUBLIN, Nov. 13, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing…